Pharmaceutical Executive-08-01-2009

Back Page
Pharmaceutical Executive

August 01, 2009

Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.

Pharmaceutical Executive
Features

August 01, 2009

The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's-all at once.

Pharmaceutical Executive
Washington Report

August 01, 2009

Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.

Pharmaceutical Executive
Column

August 01, 2009

Business schools must prepare students for the post-recession economy, not teach them principles applicable to 2003.

Pharmaceutical Executive
Features

August 01, 2009

With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.

Pharmaceutical Executive
Features

August 01, 2009

Innovative pharmaceutical companies are reaching out to physicians and consumers in an effort to get patients to take their medicine.

Pharmaceutical Executive
Columns

August 01, 2009

In an era of blurred channels and information clutter, it is critical for brand managers to develop a unified strategy that bridges the gaps between audiences.

Pharmaceutical Executive
From the Editor

August 01, 2009

Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.